Search clinical trials for: Empagliflozin Tablets
Total 7429 results
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
Christopher BellAstraZenecaCompletedWeight LossUnited States
-
Paratek Pharmaceuticals IncActive, not recruitingMycobacterium Infections, Nontuberculous | Nontuberculous Mycobacterial Lung Disease | Mycobacterium Abscessus Infection | Nontuberculous Mycobacterial Pulmonary InfectionUnited States
-
AstraZenecaRecruitingLiver CirrhosisDenmark, Spain, Germany, United States, France, Australia, China, Belgium, Netherlands, Switzerland, Austria, United Kingdom, Taiwan, Canada, Czechia
-
Rigshospitalet, DenmarkCompletedHyponatremia | Metabolic Bone DiseaseDenmark
-
University Medical Center GroningenCompletedHeart Failure; With Decompensation | Heart Failure，Congestive | Heart Failure AcuteNetherlands
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompletedHeart Failure | Diabetes MellitusUnited Kingdom
-
University Hospital TuebingenCompletedBody Weight | PreDiabetesGermany
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
Brigham and Women's HospitalUnknown
-
Medical University of ViennaAttoquant DiagnosticsCompletedDiabetes Mellitus, Type 2 | Diabetic Kidney Disease | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3Austria
-
National Taiwan University HospitalShin Kong Wu Ho-Su Memorial HospitalNot yet recruitingHeart Failure With Reduced Ejection Fraction | End Stage Renal Disease on Dialysis
-
Sinew Pharma Inc.Completed
-
LM Diagnósticos S.L.AstraZenecaUnknown
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
Saint Luke's Health SystemCompletedHeart FailureUnited States
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Austria, Germany
-
Hansoh BioMedical R&D CompanyNot yet recruitingVasomotor SymptomsChina
-
AstraZenecaCompleted
-
Shanghai Zhongshan HospitalActive, not recruiting
-
Medical University of GrazMedical University of Vienna; Johannes Kepler University of Linz; Paracelsus... and other collaboratorsCompletedAcute Myocardial InfarctionAustria
-
Ann & Robert H Lurie Children's Hospital of ChicagoNot yet recruitingNAFLD | Non-Alcoholic Fatty Liver Disease | Pediatric NAFLDUnited States
-
Valenta Pharm JSCRecruiting
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Fulcrum TherapeuticsCompletedHealthy Adult SubjectsUnited States
-
Ain Shams UniversityDrug Research Centre, Cairo, EgyptCompletedDiabetes Mellitus | Pharmacokinetics | PharmacodynamicsEgypt
-
Center for Outcomes Research and Clinical Epidemiology...Italian Society of DiabetologyNot yet recruitingDiabetes Mellitus, Type 2
-
Ann & Robert H Lurie Children's Hospital of ChicagoNot yet recruitingNon-Alcoholic Fatty Liver Disease
-
Mansoura UniversityActive, not recruitingLupus Nephritis | BMD | SGLT2 INHIBITORSEgypt
-
Overseas Pharmaceuticals, Ltd.GX pharma technology (beijing) Co., LtdActive, not recruiting
-
Medical University of ViennaRecruitingReperfusion Injury | Vascular ComplicationsAustria
-
Peking Union Medical College HospitalUnknownType 2 Diabetes MellitusChina
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
University Medical Centre LjubljanaUnknownDiabetes Complications | Diabetes Mellitus, Type 1 | Vascular Stiffness | Hypoglycemic AgentsSlovenia
-
Imperial College LondonRoyal Brompton & Harefield NHS Foundation TrustNot yet recruitingHeart Diseases | Heart Failure | Cardiomyopathies | Cardiomyopathy, Dilated
-
Boehringer IngelheimCompleted
-
Asmaa Abdelfattah ElsayedCompleted
-
SINA Health Education and Welfare TrustCompletedPolycystic Ovary Syndrome | Weight Gain | HbA1cPakistan
-
VaxartCompletedRespiratory Syncytial Virus (RSV)United States
-
University of OxfordOxford Brookes University; The Leona M. and Harry B. Helmsley Charitable TrustTerminatedDiabetes Mellitus, Type 1United Kingdom
-
University Health Network, TorontoSunnybrook Health Sciences Centre; MOUNT SINAI HOSPITALRecruitingCardiovascular Risk FactorCanada
-
LG ChemUnknown
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan